WallStreetZenWallStreetZen

NASDAQ: FULC
Fulcrum Therapeutics Inc Stock Ownership - Who owns Fulcrum Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Fulcrum Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin Tang10% Owner2026-07-1750,945$3.52
$179.33kBuy
Kevin Tang10% Owner2026-07-16116,671$3.56
$415.35kBuy
Kevin Tang10% Owner2026-07-15107,377$3.56
$382.26kBuy
Kevin Tang10% Owner2026-07-1475,952$3.58
$271.91kBuy
Kevin Tang10% Owner2026-07-1453,651$3.56
$191.00kBuy
Kevin Tang10% Owner2026-07-1312,966$3.54
$45.90kBuy
Alan EzekowitzDirector2026-06-2618,000$3.65
$65.61kSell
Robert J. GouldDirector2026-02-0215,000$10.72
$160.86kSell
Robert J. GouldDirector2026-01-0215,000$10.87
$163.10kSell
Robert J. GouldDirector2026-01-0215,000$11.87
$178.10kSell

1 of 2

FULC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FULC insiders and whales buy or sell their stock.

FULC Shareholders

What type of owners hold Fulcrum Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kevin Tang18.01%13,744,328$52.64MInsider
Ra Capital Management LP17.11%13,053,960$50.00MInsider
Mark J. Levin7.92%6,046,425$23.16MInsider
Third Rock Ventures III LP3.28%2,499,343$9.57MInsider
Third Rock Ventures IV LP3.07%2,343,154$8.97MInsider
Glaxosmithkline PLC2.34%1,785,714$6.84MInsider
Casdin Capital LLC0.79%604,285$2.31MInsider
6 Dimensions Capital LP0.73%559,821$2.14MInsider
Sanofi0.73%558,035$2.14MInsider
Section 32 Fund 2 LP0.61%464,285$1.78MInsider

1 of 3

FULC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FULC0.10%55.90%Net SellingNet Buying
IVVD0.08%31.44%Net SellingNet Selling
TRDA0.07%99.93%Net SellingNet Selling
ACIU0.02%4.41%Net Selling
AVXL0.04%4.79%Net Buying
View Top Biotech Stocks

Fulcrum Therapeutics Stock Ownership FAQ

Who owns Fulcrum Therapeutics?

Fulcrum Therapeutics (NASDAQ: FULC) is owned by 0.10% institutional shareholders, 55.90% Fulcrum Therapeutics insiders, and 43.99% retail investors. Kevin Tang is the largest individual Fulcrum Therapeutics shareholder, owning 13.74M shares representing 18.01% of the company. Kevin Tang's Fulcrum Therapeutics shares are currently valued at $52.64M.

If you're new to stock investing, here's how to buy Fulcrum Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.